Point72 Asset Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.87M Buy
+75,795
New +$6.91M 0.01% 1723
2025
Q3
Sell
-52,549
Closed -$4.85M 2730
2025
Q2
$4.85M Sell
52,549
-234,422
-82% -$18.4M 0.01% 982
2025
Q1
$25.4M Buy
286,971
+223,883
+355% +$19.4M 0.06% 383
2024
Q4
$4.85M Sell
63,088
-230,583
-79% -$16.1M 0.01% 957
2024
Q3
$12.5M Buy
293,671
+136,926
+87% +$4.62M 0.03% 570
2024
Q2
$4.1M Buy
156,745
+108,864
+227% +$2.06M 0.01% 897
2024
Q1
$437K Buy
+47,881
New +$287K ﹤0.01% 1684

Other funds holding WGS

Point72 Asset Management's WGS Position: Q1 2026 in Review

Point72 Asset Management opened a new position in GeneDx Holdings (WGS) in Q1 2026: 75,795 shares worth $4.87M. The stake represents 0.01% of the portfolio and ranks #1723 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in WGS as recently as Q2 2025.

Point72 Asset Management first reported a position in WGS in Q1 2024 and has held it in 7 quarters since. The position peaked at $25.4M in Q1 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Point72 Asset Management held 75,795 shares of GeneDx Holdings worth $4.87M as of Q1 2026.
  • GeneDx Holdings was a new Point72 Asset Management position in Q1 2026.
  • GeneDx Holdings made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1723 holding.
  • Point72 Asset Management first reported a position in GeneDx Holdings in Q1 2024 and has held it in 7 quarters since.
  • Point72 Asset Management's GeneDx Holdings position peaked at $25.4M in Q1 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.